Trial Profile
The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs PG 2 (Primary)
- Indications Cerebral haemorrhage; Stroke
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 25 Sep 2017 New trial record